HBD‑3 regulation of the immune response and the LPS/TLR4‑mediated signaling pathway

Zhu,Chen; Bao,Ni‑Rong; Chen,Shuo; Zhao,Jian‑Ning

doi:10.3892/etm.2016.3579

HBD‑3 regulation of the immune response and the LPS/TLR4‑mediated signaling pathway

Authors:
- Chen Zhu
- Ni‑Rong Bao
- Shuo Chen
- Jian‑Ning Zhao
View Affiliations

Affiliations: Department of Orthopaedic Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, P.R. China
Published online on: August 9, 2016 https://doi.org/10.3892/etm.2016.3579
Pages: 2150-2154
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the study was to investigate the mechanisms of human β‑defensin 3 (HBD‑3) regulation of the immune response and the lipopolysaccharide/Toll‑like receptor‑4 (LPS/TLR4)‑mediated signaling pathway. A TLR4 extracellular gene fragment was cloned into the pET32a plasmid to determine its expression in Escherichia coli (E. coli) and purification. A dialysis labeling method was used to stain HBD‑3 with fluorescein isothiocyanate (FITC). FITC‑HBD‑3 was used to induce the differentiation of human peripheral blood mononuclear cells (MNC) into immature dendritic cells (imDC) in vitro. Binding reactions were established using FITC‑HBD‑3 and sTLR4 into cell suspensions. Flow cytometry (FCM) was used to analyze the results. Western blot analysis confirmed the identity of nuclear factor‑κB (NF‑κB) and was used to quantify its nuclear translocation. The results showed that, HBD‑3 bound to imDC in a Ca2+‑dependent manner, and sTLR4 and LPS competitively inhibited the binding. HBD‑3 competitively blocked the binding of LPS and imDC by binding to imDC. HBD‑3 significantly decreased the translocation of LPS‑induced NF‑κB into the nucleus. In conclusion, HBD‑3 can competitively inhibit the binding of LPS and imDC through its binding to TLR4 molecules, which are expressed in imDC, thereby preventing LPS from inducing the maturity of the imDCs.

View Figures

View References

1	Montanaro L, Speziale P, Campoccia D, Ravaioli S, Cangini I, Pietrocola G, Giannini S and Arciola CR: Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol. 6:1329–1349. 2011. View Article : Google Scholar : PubMed/NCBI
2	Zhu C, Tan H, Cheng T, Shen H, Shao J, Guo Y, Shi S and Zhang X: Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res. 183:204–213. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ning R, Zhang X, Guo X and Li Q: Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappaB signaling pathway in human osteoblasts. Braz J Infect Dis. 15:189–194. 2011. View Article : Google Scholar : PubMed/NCBI
4	Jarczak J, Kościuczuk EM, Lisowski P, Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski L and Bagnicka E: Defensins: natural component of human innate immunity. Hum Immunol. 74:1069–1079. 2013. View Article : Google Scholar : PubMed/NCBI
5	Zhu C, He N, Cheng T, Tan H, Guo Y, Chen D, Cheng M, Yang Z and Zhang X: Ultrasound-targeted microbubble destruction enhances human β-defensin 3 activity against antibiotic-resistant Staphylococcus biofilms. Inflammation. 36:983–996. 2013. View Article : Google Scholar : PubMed/NCBI
6	Hinrichsen K, Podschun R, Schubert S, Schröder JM, Harder J and Proksch E: Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother. 52:1876–1879. 2008. View Article : Google Scholar : PubMed/NCBI
7	Röhrl J, Yang D, Oppenheim JJ and Hehlgans T: Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J Biol Chem. 283:5414–5419. 2008. View Article : Google Scholar : PubMed/NCBI
8	Hancock RE and Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 24:1551–1557. 2006. View Article : Google Scholar : PubMed/NCBI
9	Shi Y, Song W, Feng ZH, Zhao YT, Li F, Tian Y and Zhao YM: Disinfection of maxillofacial silicone elastomer using a novel antimicrobial agent: recombinant human beta-defensin-3. Eur J Clin Microbiol Infect Dis. 28:415–420. 2009. View Article : Google Scholar : PubMed/NCBI
10	Varoga D, Wruck CJ, Tohidnezhad M, Brandenburg L, Paulsen F, Mentlein R, Seekamp A, Besch L and Pufe T: Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. Histochem Cell Biol. 131:207–218. 2009. View Article : Google Scholar : PubMed/NCBI
11	Semple F, MacPherson H, Webb S, Cox SL, Mallin LJ, Tyrrell C, Grimes GR, Semple CA, Nix MA, Millhauser GL, et al: Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol. 41:3291–3300. 2011. View Article : Google Scholar : PubMed/NCBI
12	Röhrl J, Yang D, Oppenheim JJ and Hehlgans T: Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol. 184:6688–6694. 2010. View Article : Google Scholar : PubMed/NCBI
13	Zhu C, Qin H, Cheng T, Tan HL, Guo YY, Shi SF, Chen DS and Zhang XL: Staphylococcus aureus supernatant induces the release of mouse β-defensin-14 from osteoblasts via the p38 MAPK and NF-κB pathways. Int J Mol Med. 31:1484–1494. 2013.PubMed/NCBI
14	Zhu C, Wang J, Cheng T, Li Q, Shen H, Qin H, Cheng M and Zhang X: The potential role of increasing the release of mouse β-defensin-14 in the treatment of osteomyelitis in mice: a primary study. PLoS One. 9:e868742014. View Article : Google Scholar : PubMed/NCBI
15	Wang M, Chen Y, Zhang Y, Zhang L, Lu X and Chen Z: Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cell Mol Immunol. 8:265–275. 2011. View Article : Google Scholar : PubMed/NCBI
16	Spadaro M, Montone M, Arigoni M, Cantarella D, Forni G, Pericle F, Pascolo S, Calogero RA and Cavallo F: Recombinant human lactoferrin induces human and mouse dendritic cell maturation via Toll-like receptors 2 and 4. FASEB J. 28:416–429. 2014. View Article : Google Scholar : PubMed/NCBI